Hepatic gene expression of Esrrg was upregulated 2.4-fold in a study on candidate genes that affect lipid and lipoprotein metabolism in response to fenofibrate treatment, interestingly the same treatment induced remission of lipoprotein glomerulopathy in patients with the apoE Kyoto mutation [15], [37]. Here, ESRRG is linked to lipoprotein glomerulopathy.